|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 151 FARMINGTON AVENUE |
Address2 | |
City | HARTFORD |
State | CT |
Zip Code | 06156 |
Country | USA |
3. Principal place of business (if different than line 2)
City | |
State | |
Zip Code | |
Country | |
|
5. Senate ID# 352-12
|
||||||||
|
6. House ID# 321570000
|
TYPE OF REPORT | 8. Year | 2008 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date | |
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Jonathan M. Topodas, Vice President and Counsel |
Date | 07/10/2008 |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
HR 3162, Children's Health & Medicare Protection Act of 2007 (Medicare Payment/Reimbursement Reform); S.1218/HR 2034, Medicare for All Act (Medicare "buy-in"); S. 130/HR 1990, Medicare Cost Contract Extension & Retirement Act of 2007 (private sector role in Medicare); S 3/HR 4, Medicare Prescription Drug Price Negotiation Act of 2007 (Government Negotiation of Medicare Drug Prices); S 1102, Part D Equity for Low Income Seniors Act of 2007 (Special benefits for low income seniors);
HR 1663, Medicare Mental Health Modernization Act of 2007 (Medicare Mental Health Parity); HR 976, Children's Health Insurance Program Reauthorization Act of 2007 (SHIP Extension and Expansion); HR 2184, Enhanced Health Care Value for All Act of 2007 (Comparative Effectiveness Research Institute; HR 971, Community Pharmacy Fairness Act of 2007 (Medicare Pharmacist Antitrust Exemption), HR 4327, Medicare Chronic Care Practice Network (Establish a Medicare Chronic Care Practice Research Network to develop and evaluate evidence based chronic care management for Medicare beneficiaries); HR 1193, Kidney Care Quality and Education Act of 2007 (Modernize and improve the Medicare ESRD program); HR 6331/S.3103, Medicare Improvements Act (dealing with physician reimbursements and Medicare Advantage funding cuts)
17. House(s) of Congress and Federal agencies Check if None
Executive Office of the President (EOP), Health & Human Services - Dept of (HHS), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jonathan |
Topodas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
S 1893, Children's Health Insurance Program Reauthorization Act of 2007 (Expansion/extension of SCHIP ); S558/HR 1424, Mental Health Parity Act of 2007 (Secure equal treatment for mental health benefits); HR 1038/S 623, Access to Life-Saving Medicine Act (Biogenerics-approving generic Bio pharmaceuticals); S 316, Preserve Access to Affordable Generics Act (Regulate Generic/Brand patent settlements); S 1501/S 1695, Affordable Biologics for Consumers Act (Generic Bio-pharmaceuticals);
S 334, Healthy Americans Act (Universal health coverage replaces employer coverage); S 1368 Personalized Health Information Act of 2007 (Health information technology);S 1899, Universal Health Coverage Act of 2007 (Mandatory health insurance coverage); S 242/HR 380, Pharmaceutical Market Access and Drug Safety Act of 2007 (Drug importation-Canada, et al.); HR 1076/S616, HIPAA Recreational Injury Technical/Correction Act (Mandatory coverage for recretional activity); HR 676, United States National Health Insurance Act (National health insurance); HR 1368, Personalized Health Information Act of 2007 (Financial incentives for personal health records); S 1490, Federal Employees Electronic Personal Health Records Act of 2007 (health information technology); S 1544, Medicare Quality Enhancement Act of 2007 (CMS data release); S 1693, Wired for Health Care Quality Act (Health information technology); HR 1368, Personalized Health Information Act of 2007; HR 5422, TRUST in Health Information Act of 2008; S 1693, Wired for Health Care Quality Act; S 1814, Health Information Privacy and Security Act
17. House(s) of Congress and Federal agencies Check if None
Executive Office of the President (EOP), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jonathan |
Topodas |
|
|
|
Charlyn |
Iovino |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
HR 493/S 358, Genetic Information Nondiscrimination Act of 2007; H 2761, Terrorism Risk Insurance Revision and Extension Act of 2007 (Include life insurance provision); S1588, Children's Access to Reconstructive Evaluation and Surgery Act (Mandated coverage for congenital disease/deformity); H836, Cyber-Security Enhancement and Consumer Data Protection Act of 2007 (Privacy and data security provisions); HR 948, Social Security Number Protection Act of 2007; S 495, Personal Data Privacy and
Security Act of 2007; S 1408, Health Information Technology Act of 2007 (Provision on using technology for quality); HR 3425, Cancer Screening Coverage Act of 2007 (Mandated cancer screening); HR 3341, Quality Health Care Coalition Act of 2007 (Provision exempting physicians from antitrust laws); S 459/HR 758, Breast Cancer Patient Protection Act of 2007 (Minimum hospital stay for breast cancer); S 40, National Insurance Act of 2007 (Optional federal charter for insurance); S 400/HR 2851, Michelle's Law (Mandatory coverage for students when on medical leave); HR 4460/S 2477, Health Care Choice Act of 2007 (Cross-state selling of insurance); S 358/HR 493, Genetic Information Non discrimination Act of 2007; HR 4986, National Defense Authorization Act for Fiscal Year 2008 (Provision that extends Family Medical Leave Act to service members); S 1881/HR 3195, ADA Restoration Act of 2007
17. House(s) of Congress and Federal agencies Check if None
Treasury - Dept of, U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charlyn |
Iovino |
|
|
|
Jonathan |
Topodas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
S1481/HR 2497, Fair and Reliable Medical Justice Act (Medical malpractice reform/health courts); S618, Insurance Competition Act of 2007 (Repeal McCarran-Ferguson); HR 3341, Quality Health Care Coalition Act (Physician antitrust exemption)
17. House(s) of Congress and Federal agencies Check if None
Executive Office of the President (EOP), U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Jonathan |
Topodas |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
HR 914, Tax equity and Affordability Act of 2007; HR 2639, Promoting Health for Future Generations Act of 2007; HS 3234, HSA Improvement and Expansion Act of 2007, S 46, Affordability in the Individual Market Act; S 397, Tax Equity and Affordability Act of 2007
17. House(s) of Congress and Federal agencies Check if None
Executive Office of the President (EOP), Treasury - Dept of, U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charlyn |
Iovino |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code RET
16. Specific lobbying issues
HR 3361, Pension Protection Technical Corrections Act of 2008
17. House(s) of Congress and Federal agencies Check if None
Executive Office of the President (EOP), Treasury - Dept of, U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Charyln |
Iovino |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address | |
||||||
City | |
State | |
Zip Code | |
Country | |
21. Client new principal place of business (if different than line 20)
City | |
State | |
Zip Code | |
Country | |
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
5 |
|
||||||
2 |
|
6 |
|
||||||
3 |
|
7 |
|
||||||
4 |
|
8 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 3 | 5 |
2 | 4 | 6 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 5 | 9 |
2 | 6 | 10 |
3 | 7 | 11 |
4 | 8 | 12 |